Donna L. Farber

Donna L. Farber

Top Cited Scholar 2026
Auto-generated profile, based on publicly available information

Donna L. Farber

Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, USA

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 September 2011 in Nature Immunology
Verified
Journal Article
Closed access
LMLaurel A Monticelli
Laurel A Monticelli
GSGregory F Sonnenberg
Gregory F Sonnenberg
MAMichael C Abt
Michael C Abt
TATheresa Alenghat
Theresa Alenghat
CZCarly G K Ziegler
Carly G K Ziegler
DADavid Artis
David Artis

13 May 2022 in Science
Verified
Journal Article
Open access
CCC. Domínguez Conde
C. Domínguez Conde
CXC. Xu
C. Xu
LJL. B. Jarvis
L. B. Jarvis
DRD. B. Rainbow
D. B. Rainbow
SWS. B. Wells
S. B. Wells
STS. A. Teichmann
S. A. Teichmann
Despite their crucial role in health and disease, our knowledge of immune cells within human tissues remains limited. We surveyed the immune compartment of 16 tissues from 12 adult donors by single-cell RNA sequencing and VDJ sequencing generating a dataset of ~360,000 cells. To systematically resolve immune cell heterogeneity across tissues, we developed CellTypist, a machine learning tool for rapid and precise cell type annotation. Using this approach, combined with detailed curation, we determined the tissue distribution of finely phenotyped immune cell types, revealing hitherto unappreciated tissue-specific features and clonal architecture of T and B cells. Our multitissue approach lays the foundation for identifying highly resolved immune cell types by leveraging a common reference dataset, tissue-integrated expression analysis, and antigen receptor sequencing.

1 February 2018 in Immunity
Verified
Journal Article
Closed access
BKBrahma V. Kumar
Brahma V. Kumar
TCThomas J. Connors
Thomas J. Connors
DFDonna L. Farber
Donna L. Farber

1 September 2017 in Cell Reports
Verified
Journal Article
Open access
BKBrahma V. Kumar
Brahma V. Kumar
WMWenji Ma
Wenji Ma
MMMichelle Miron
Michelle Miron
TGTomer Granot
Tomer Granot
RGRebecca S. Guyer
Rebecca S. Guyer
DFDonna L. Farber
Donna L. Farber
Tissue-resident memory T cells (TRMs) in mice mediate optimal protective immunity to infection and vaccination, while in humans, the existence and properties of TRMs remain unclear. Here, we use a unique human tissue resource to determine whether human tissue memory T cells constitute a distinct subset in diverse mucosal and lymphoid tissues. We identify a core transcriptional profile within the CD69+ subset of memory CD4+ and CD8+ T cells in lung and spleen that is distinct from that of CD69- TEM cells in tissues and circulation and defines human TRMs based on homology to the transcriptional profile of mouse CD8+ TRMs. Human TRMs in diverse sites exhibit increased expression of adhesion and inhibitory molecules, produce both pro-inflammatory and regulatory cytokines, and have reduced turnover compared with circulating TEM, suggesting unique adaptations for in situ immunity. Together, our results provide a unifying signature for human TRM and a blueprint for designing tissue-targeted immunotherapies.

13 December 2013 in Nature Reviews Immunology
Verified
Journal Article
Open access
PDF file
DFDonna L. Farber
Donna L. Farber
NYNaomi A. Yudanin
Naomi A. Yudanin
NRNicholas P. Phillip Restifo
Nicholas P. Phillip Restifo
Most of our understanding of memory T cell generation, function and maintenance comes from mouse studies, which cannot recapitulate the exposure to diverse antigens and microbiota that occurs over many decades in humans. Memory T cell frequency dynamically changes throughout the human lifetime and this can be divided into three phases: memory generation, memory homeostasis and immunosenescence. CD45RO+CD45RA− T cells comprise diverse memory T cell subsets, including central memory T (TCM) cells, effector memory T (TEM) cells, stem cell memory T (TSCM) cells and tissue-resident memory T (TRM) cells, which are heterogeneous in their generation, distribution and function. Memory T cells that are specific for antigens from ubiquitous pathogens and possibly from endogenous flora are generated early in life and are preferentially compartmentalized at the sites of infection throughout adulthood. Human memory T cells in diverse tissue sites are homeostatically maintained, potentially through tonic T cell receptor signalling, and can show extensive cross reactivity and can persist for decades. The induction of memory CD4+ and CD8+ T cells through vaccination can enhance protection against pathogens, and might be improved by considering the anatomical location and the timing of vaccine administration during the early stages of life.

17 October 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
PSPeter A Szabo
Peter A Szabo
HLHanna Mendes Levitin
Hanna Mendes Levitin
MMMichelle Miron
Michelle Miron
MSMark E Snyder
Mark E Snyder
TSTakashi Senda
Takashi Senda
PSPeter A Sims
Peter A Sims
Human T cells coordinate adaptive immunity in diverse anatomic compartments through production of cytokines and effector molecules, but it is unclear how tissue site influences T cell persistence and function. Here, we use single cell RNA-sequencing (scRNA-seq) to define the heterogeneity of human T cells isolated from lungs, lymph nodes, bone marrow and blood, and their functional responses following stimulation. Through analysis of >50,000 resting and activated T cells, we reveal tissue T cell signatures in mucosal and lymphoid sites, and lineage-specific activation states across all sites including distinct effector states for CD8+ T cells and an interferon-response state for CD4+ T cells. Comparing scRNA-seq profiles of tumor-associated T cells to our dataset reveals predominant activated CD8+ compared to CD4+ T cell states within multiple tumor types. Our results therefore establish a high dimensional reference map of human T cell activation in health for analyzing T cells in disease.